Published works by Robbie Jost

Published works

• The Hidden Ingredient Problem: PFAS Litigation and Regulation Are Reshaping the Beauty Industry

  Retail & Consumer Products Law Observer · May 19, 2026

  LEX-WK-G0X52EKY
• How Food, Beverage Claims May Preview Cosmetic Litigation

  Retail & Consumer Products Law Observer · April 27, 2026

  LEX-WK-KBJCT6X5
• Cosmetics Under the Microscope: FDA’s Expanding Regulatory Reach Under MoCRA

  Retail & Consumer Products Law Observer · April 8, 2026

  LEX-WK-VQRJ24AM
• MoCRA Under the Trump Era: A Look at FDA’s Monitoring and Enforcement Two Months In

  Retail & Consumer Products Law Observer · March 27, 2025

  LEX-WK-KF1YJ5R6
• The Ink is Dry: FDA Issues Final Guidance for Tattoo Industry

  Retail & Consumer Products Law Observer · October 29, 2024

  LEX-WK-X954DH0B
• Cosmetics Direct Gets Two Portal “Fillers” – Discontinuation & Relisting Features Added

  Retail & Consumer Products Law Observer · August 5, 2024

  LEX-WK-CAH8DBNS
• FDA Unveils Its “First Look” Into How It Will Enforce MoCRA

  Retail & Consumer Products Law Observer · July 1, 2024

  LEX-WK-RSET3MRP
• Talc About Toxic-Free Cosmetics

  Retail & Consumer Products Law Observer · May 21, 2024

  LEX-WK-H5ZQ0X9T
• Is it Allowed? Companies Face New Challenges with an Ever-Evolving List of “Off Limits” Ingredients in Cosmetic Products

  Retail & Consumer Products Law Observer · May 7, 2024

  LEX-WK-3VH1CYBP
• MedTech Article Discusses FDA Authority Over Bassinet

  Retail & Consumer Products Law Observer · June 1, 2023

  LEX-WK-MQZYNYR0
• The FDA Appears to Expand Its Definition of a “Medical Device” to Include CPSC-Regulated Infant Sleep Products

  Retail & Consumer Products Law Observer · April 27, 2023

  LEX-WK-7ZT1C0GZ
• FDA Issues Final Guidance on Clinical Decision Support Software

  Health Law · October 10, 2022

  LEX-WK-PB86VCDZ